Contact
Please use this form to send email to PR contact of this press release:
GSK receives US approval for once-weekly type 2 diabetes treatment, TanzeumTM (albiglutide)
TO:
Please use this form to send email to PR contact of this press release:
GSK receives US approval for once-weekly type 2 diabetes treatment, TanzeumTM (albiglutide)
TO: